Evidence map›Paper›PMID 33912981›Full record

ArticleDiabetologia2021

Identification and characterisation of tertiary lymphoid organs in human type 1 diabetes.

Éva Korpos, Nadir Kadri, Sophie Loismann, Clais R Findeisen, Frank Arfuso, George W Burke, Sarah J Richardson, Noel G Morgan, Marika Bogdani, Alberto Pugliese and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Diabetologia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Éva KorposInstitute of Physiological Chemistry and Pathobiochemistry, University of Muenster, Muenster, Germany. korpos@uni-muenster.de.ORCID http://orcid.org/0000-0002-0438-4211
Nadir KadriScience for Life Laboratory, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Solna, Stockholm, Sweden.ORCID https://orcid.org/0000-0003-2623-4094
Sophie LoismannInstitute of Physiological Chemistry and Pathobiochemistry, University of Muenster, Muenster, Germany.
Clais R FindeisenInstitute of Physiological Chemistry and Pathobiochemistry, University of Muenster, Muenster, Germany.ORCID https://orcid.org/0000-0002-9720-0433
Frank ArfusoInstitute of Physiological Chemistry and Pathobiochemistry, University of Muenster, Muenster, Germany.ORCID https://orcid.org/0000-0001-7678-9472
George W BurkeDepartment of Surgery, Division of Transplantation, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, USA.ORCID https://orcid.org/0000-0002-6888-2842
Sarah J RichardsonInstitute of Biomedical & Clinical Science, University of Exeter, Exeter, UK.ORCID https://orcid.org/0000-0002-1160-6062
Noel G MorganInstitute of Biomedical & Clinical Science, University of Exeter, Exeter, UK.ORCID https://orcid.org/0000-0003-1537-8113
Marika BogdaniMatrix Biology Program, Benaroya Research Institute, Seattle, WA, USA.ORCID https://orcid.org/0000-0002-4677-7523
Alberto PuglieseDiabetes Research Institute, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, USA.ORCID https://orcid.org/0000-0002-7211-0319
Lydia SorokinInstitute of Physiological Chemistry and Pathobiochemistry, University of Muenster, Muenster, Germany.ORCID https://orcid.org/0000-0001-7704-7921
University of Exeter · GBUniversity of Miami · USKarolinska University Hospital · SEMatrix Research (United States) · USUniversity of Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aims/hypothesisWe and others previously reported the presence of tertiary lymphoid organs (TLOs) in the pancreas of NOD mice, where they play a role in the development of type 1 diabetes. Our aims here are to investigate whether TLOs are present in the pancreas of individuals with type 1 diabetes and to characterise their distinctive features, in comparison with TLOs present in NOD mouse pancreases, in order to interpret their functional significance.

methodsUsing immunofluorescence confocal microscopy, we examined the extracellular matrix (ECM) and cellular constituents of pancreatic TLOs from individuals with ongoing islet autoimmunity in three distinct clinical settings of type 1 diabetes: at risk of diabetes; at/after diagnosis; and in the transplanted pancreas with recurrent diabetes. Comparisons were made with TLOs from 14-week-old NOD mice, which contain islets exhibiting mild to heavy leucocyte infiltration. We determined the frequency of the TLOs in human type 1diabetes with insulitis and investigated the presence of TLOs in relation to age of onset, disease duration and disease severity.

resultsTLOs were identified in preclinical and clinical settings of human type 1 diabetes. The main characteristics of these TLOs, including the cellular and ECM composition of reticular fibres (RFs), the presence of high endothelial venules and immune cell subtypes detected, were similar to those observed for TLOs from NOD mouse pancreases. Among 21 donors with clinical type 1 diabetes who exhibited insulitis, 12 had TLOs and had developed disease at younger age compared with those lacking TLOs. Compartmentalised TLOs with distinct T cell and B cell zones were detected in donors with short disease duration. Overall, TLOs were mainly associated with insulin-containing islets and their frequency decreased with increasing severity of beta cell loss. Parallel studies in NOD mice further revealed some differences in so far as regulatory T cells were essentially absent from human pancreatic TLOs and CCL21 was not associated with RFs. CONCLUSIONS/

interpretationWe demonstrate a novel feature of pancreas pathology in type 1 diabetes. TLOs represent a potential site of autoreactive effector T cell generation in islet autoimmunity and our data from mouse and human tissues suggest that they disappear once the destructive process has run its course. Thus, TLOs may be important for type 1 diabetes progression.

Indexed as

AdolescentAdultAgedAged, 80 and overAnimalsAutoantibodiesAutoimmunityChildChild, PreschoolDiabetes Mellitus, Type 1FemaleHumansIslets of LangerhansMaleMiceMice, Inbred NODAutoantibodiesAutoimmunityBasement membraneFibroblastic reticular cellsHigh endothelial venulesLymph nodeReticular fibresTertiary lymphoid organsTransplantationType 1 diabetes

Identifiers

PMID33912981
PMCPMC8187221
OpenAlexW3158990914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.